San Francisco Chronicle
Insight: From cakes to tech, bold startups defy Portugal crisis
Cell2B is preparing for clinical trials of promising cell therapies aimed at eliminating transplant rejection in humans, after which the founders do not rule out a share offering. Nuno Carvalho, 34-year-old CEO of The Portuguese Bakery, says a crisis ...
Laboratory instruments are seen at the Cell2B biomedical company near Lisbon